Asgard Therapeutics announces the expansion of its leadership team with the recent appointment of Dr Alan Griffith as a Chief Development Officer.
Read moreAsgard Therapeutics announces appointment of three members Axel Schambach, MD PhD, Johanna Olweus, MD PhD, and Joshua Brody, MD to its Newly Formed Scientific Advisory Board (SAB).
Read moreAsgard Therapeutics was featured at the Nature Biopharma dealmakers new collection, highlighting companies developing innovative cell and gene therapies. Take a closer look at how Asgard’s in-vivo direct reprogramming approach can convert tumor cells into antigen-presenting dendritic cells and turn cold tumors hot.
Read moreFrom a collective of 40 selected start-ups, Asgard Therapeutics was awarded the runner-up prize as part of the NLSDays Investment Track.
Read moreLund, Sweden, 13 September 2022 – Asgard Therapeutics AB (“Asgard”), a private biotech company pioneering...
Read moreLund, Sweden – 01 June – Asgard Therapeutics AB (“Asgard”) today announces that the United States...
Read moreAsgard Therapeutics announces today that the Eurostars-funded project REPRogramming tumors INTo immune cells - a revolutionary gene therapy to treat cancer (REPRINT) - has officially kicked-off.
Read moreThe world wealthiest look for cellular reprogramming as the key for longevity with limitless funds for research
Read moreExiting! @AsgardThx has been named the winner of the highly competitive 'EIC ePitching with Investors' contest, after being selected from over 80 applications and competing with 7 other companies. Thank you @EUeic for hosting this event!
#innovation #pitching #cancer
Fábio Rosa Co-founder and Head of Research at @AsgardThx is going to speak at the networking event about opportunities within companies for performing their Master's Thesis. More details: http://bit.ly/3Su7RWB
#AsgardTherapeutics #immunotherapy #thesis
We are thrilled to share this wonderful news! Co-founder and Head of Innovation at @AsgardThx @CellReproLab together with members of his laboratory at @lunduniversity were awarded a Proof of Concept Grant from the @ERC_Research.
#reprogramming #Immunotherapy
We are pleased to introduce Tiffany Schärer, who is currently working on establishing tumor organoids to validate the efficacy of our cancer immunotherapy product ex vivo as part of her Master's thesis at @AsgardThx.
Welcome to the team, Tiffany!
#team #Immunotherapy
Check out the newest feature in @bpdealmakers that selected @AsgardThx platform technology as an innovative gene therapy to reprogram anti-cancer immunity. #Immunotherapy #biopharma https://www.nature.com/articles/d43747-022-00220-4
Check out the newest feature in @bpdealmakers that selected @AsgardThx platform technology as an innovative gene therapy to reprogram anti-cancer immunity. #Immunotherapy #biopharma https://www.nature.com/articles/d43747-022-00220-4
We are excited to be part of the #NLSdays and network in this vibrant environment.
Feel free to reach out to @_CristianaPires and Fabio Rosa to know more about our mission in #cancerimmunotherapy.
#asgardthx #startup #innovation
Join @AsgardThx welcoming Martin Bonde as our new Chair of the Board of Directors.
Welcome to team Martin! http://bit.ly/3DpQReq
7-year journey = 7 words in my new title:
Professor in #molecular #medicine, #regeneration, #transplantation and #repair in the #hematopoietic #system.
Full Professor at @medfak_LU @lunduniversity, what’s next?
@Lund_Stem @LuWcmm
Congrats to @AsgardThx and Filipe Pereira (@CellReproLab), winners of the 2020 ISMMS-KiiLN award, on their seed round and growing team! @MtSinaiPostdocs @MountSinaiAlum @IcahnMountSinai @ISMMSPostdocOff @MountSinai_IP #SINAInnovations http://shorturl.at/otJT5
;